Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor + GCSF for First-line Stem Cell Mobilization in Children
NCT02006225Phase 4Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Feb 2014
- Primary completion
- Feb 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of plerixafor in neuroblastoma, medulloblastoma, primitive neuroectodermal tumor (PNET), sarcoma, lymphoma, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
plerixafor
03
Conditions
neuroblastomamedulloblastomaprimitive neuroectodermal tumor (PNET)sarcomalymphoma
Beyond the preview
Go deeper on NCT02006225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02006225.